As of January 23, 2025, Lipella Pharmaceuticals (LIPO) has a market cap of $3.445 million USD. According to our data, Lipella Pharmaceuticals is ranked No.9119 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $3.45 M |
-6.56%
|
Dec 31, 2024 | $3.69 M |
-62.62%
|
Dec 29, 2023 | $9.86 M |
-67.41%
|
Dec 30, 2022 | $30.27 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Abeona Therapeutics
ABEO
|
$0.22 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Market Cap | = | LIPO Stock Price | * | LIPO Shares Outstanding |
= | $2.85 | * | 1.21 M | |
= | $3.45 M |